RETRACTED: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo P Anand, HB Nair, B Sung, AB Kunnumakkara, VR Yadav, RR Tekmal, ... Biochemical pharmacology 79 (3), 330-338, 2010 | 786 | 2010 |
RETRACTED: Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential J Ravindran, HB Nair, B Sung, S Prasad, RR Tekmal, BB Aggarwal Biochemical pharmacology 79 (11), 1640-1647, 2010 | 194 | 2010 |
Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation HB Nair, R Luthra, N Kirma, YG Liu, L Flowers, D Evans, RR Tekmal Cancer research 65 (23), 11164-11173, 2005 | 123 | 2005 |
Elevated Expression of the Oncogene c-fms and Its Ligand, the Macrophage Colony-Stimulating Factor-1, in Cervical Cancer and the Role of Transforming Growth Factor-β1 … N Kirma, LS Hammes, YG Liu, HB Nair, PT Valente, S Kumar, LC Flowers, ... Cancer research 67 (5), 1918-1926, 2007 | 85 | 2007 |
Modeling the early endometriotic lesion: mesothelium-endometrial cell co-culture increases endometrial invasion and alters mesothelial and endometrial gene transcription AS Nair, HB Nair, RS Lucidi, AJ Kirchner, RS Schenken, RR Tekmal, ... Fertility and sterility 90 (4), 1487-1495, 2008 | 73 | 2008 |
Overexpression of the Colony-Stimulating Factor (CSF-1) and/or Its Receptor c-fms in Mammary Glands of Transgenic Mice Results in Hyperplasia and Tumor … N Kirma, R Luthra, J Jones, YG Liu, HB Nair, U Mandava, RR Tekmal Cancer research 64 (12), 4162-4170, 2004 | 70 | 2004 |
Targeting LIF/LIFR signaling in cancer S Viswanadhapalli, KV Dileep, KYJ Zhang, HB Nair, RK Vadlamudi Genes & Diseases 9 (4), 973-980, 2022 | 68 | 2022 |
EC359: a first-in-class small-molecule inhibitor for targeting oncogenic LIFR signaling in triple-negative breast cancer S Viswanadhapalli, Y Luo, GR Sareddy, B Santhamma, M Zhou, M Li, ... Molecular cancer therapeutics 18 (8), 1341-1354, 2019 | 66 | 2019 |
Modeling ductal carcinoma in situ: a HER2–Notch3 collaboration enables luminal filling CR Pradeep, WJ Köstler, M Lauriola, RZ Granit, F Zhang, J Jacob-Hirsch, ... Oncogene 31 (7), 907-917, 2012 | 64 | 2012 |
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling H Singhal, ME Greene, AL Zarnke, M Laine, R Al Abosy, YF Chang, ... Oncotarget 9 (4), 4282, 2018 | 63 | 2018 |
Induction of endometrial epithelial cell invasion and c-fms expression by transforming growth factor beta Y Liu, RR Tekmal, PA Binkley, HB Nair, RS Schenken, NB Kirma Molecular human reproduction 15 (10), 665-673, 2009 | 59 | 2009 |
Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice RR Tekmal, YG Liu, HB Nair, J Jones, RP Perla, DB Lubahn, KS Korach, ... The Journal of steroid biochemistry and molecular biology 95 (1-5), 9-15, 2005 | 48 | 2005 |
Modulation of in Situ Estrogen Synthesis by Proline-, Glutamic Acid-, and Leucine-Rich Protein-1: Potential Estrogen Receptor Autocrine Signaling Loop in Breast … R Rajhans, HB Nair, SS Nair, V Cortez, K Ikuko, NB Kirma, D Zhou, ... Molecular endocrinology 22 (3), 649-664, 2008 | 37 | 2008 |
Increased expression of macrophage colony–stimulating factor and its receptor in patients with endometriosis NM Budrys, HB Nair, YG Liu, NB Kirma, PA Binkley, S Kumar, ... Fertility and sterility 97 (5), 1129-1135. e1, 2012 | 35 | 2012 |
Hyaluronic acid-bound letrozole nanoparticles restore sensitivity to letrozole-resistant xenograft tumors in mice HB Nair, S Huffman, P Veerapaneni, NB Kirma, P Binkley, RP Perla, ... Journal of nanoscience and nanotechnology 11 (5), 3789-3799, 2011 | 31 | 2011 |
Estrogen receptor-β activation in combination with letrozole blocks the growth of breast cancer tumors resistant to letrozole therapy HB Nair, NB Kirma, M Ganapathy, RK Vadlamudi, RR Tekmal Steroids 76 (8), 792-796, 2011 | 29 | 2011 |
Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma BR Hall, A Cannon, C Thompson, B Santhamma, A Chavez-Riveros, ... Genes & cancer 10 (1-2), 1, 2019 | 26 | 2019 |
BU-32: a novel proteasome inhibitor for breast cancer JK Agyin, B Santhamma, HB Nair, SS Roy, RR Tekmal Breast Cancer Research 11, 1-13, 2009 | 26 | 2009 |
Growth inhibitory efficacy of Cornus officinalis in a cell culture model for triple‑negative breast cancer NT Telang, HB Nair, GYC Wong Oncology letters 17 (6), 5261-5266, 2019 | 25 | 2019 |
Gossypin as a novel selective dual inhibitor of V-RAF murine sarcoma viral oncogene homolog B1 and cyclin-dependent kinase 4 for melanoma S Bhaskaran, KV Dileep, SS Deepa, C Sadasivan, M Klausner, ... Molecular cancer therapeutics 12 (4), 361-372, 2013 | 25 | 2013 |